{
    "clinical_study": {
        "@rank": "92498", 
        "arm_group": [
            {
                "arm_group_label": "Theophylline with azithromycin", 
                "arm_group_type": "Experimental", 
                "description": "steady-state plasma concentration of theophylline in the presence of azithromycin"
            }, 
            {
                "arm_group_label": "Theophylline alone", 
                "arm_group_type": "Active Comparator", 
                "description": "steady-state plasma concentration of theophylline alone"
            }
        ], 
        "brief_summary": {
            "textblock": "Macrolides are potent inhibitors of cytochrome P450 isoenzyme 3A4\uff08CYP3A4\uff09and thus interfere\n      with the pharmacokinetics of many other drugs that are metabolised by this enzyme like\n      theophylline.The aim of this study is to determine whether azithromycin can effect\n      theophylline  metabolism in patients."
        }, 
        "brief_title": "Drug Interaction Study of Azithromycin and Theophylline", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Chronic Obstructive Pulmonary Disease", 
            "Asthma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Asthma", 
                "Lung Diseases", 
                "Respiration Disorders", 
                "Pulmonary Disease, Chronic Obstructive", 
                "Lung Diseases, Obstructive"
            ]
        }, 
        "detailed_description": {
            "textblock": "In this non-blinded,auto-control study,patients with Chronic Obstructive Pulmonary\n      Disease\uff08COPD\uff09or asthma will serve as their own controls during the 2-week treatment\n      phase.The subjects will be co-administered oral doses of sustained release theophylline\n      (100mg tablets,twice daily) and azithromycin (2x250mg capsules,once daily )in the first\n      week.Then patients will received theophylline therapy alone with the same dose in the second\n      week.Blood samples for the measurement of theophylline plasma concentrations will be\n      collected on Days 8 and 15 prior to dosing.All adverse events whether elicited by query,\n      spontaneously reported or observed by clinic staff will be evaluated by the investigator and\n      reported in the subject's case report form."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients with COPD or asthma\uff0caged 18-75 years;\n\n          -  regularly visiting our hospital;\n\n          -  meeting the indications for azithromycin and theophylline simultaneously;\n\n        Exclusion Criteria:\n\n          -  patients with renal or hepatic dysfunction;\n\n          -  patients with congestive heart failure;\n\n          -  patients with hypothyroidism or hyperthyroidism;\n\n          -  patients taking drugs likely to affect the theophylline metabolism in the preceding\n             week;\n\n          -  patients with severe chronic obstructive pulmonary disease,asthma or respiratory\n             infection;"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02023554", 
            "org_study_id": "81302846-1"
        }, 
        "intervention": [
            {
                "arm_group_label": "Theophylline with azithromycin", 
                "description": "Drug: Theophylline(100mg,sustained release tablets). Multi-dose of theophylline(100mg,twice daily) will administered at 8 am and 8 pm from day 1 to day 7.\nDrug:Azithromycin(250mg, capsules). Multi-dose of azithromycin(500mg,once daily) will administered at  8 pm from day 1 to day 7.", 
                "intervention_name": "Theophylline with azithromycin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Theophylline alone", 
                "description": "Drug: Theophylline(100mg,sustained release tablet). Multi-dose of theophylline(100mg,twice daily) will administered at 8 am and 8 pm from day 8 to day 14.", 
                "intervention_name": "Theophylline alone", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Theophylline", 
                "Azithromycin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "azithromycin", 
            "theophylline", 
            "CYP3A4"
        ], 
        "lastchanged_date": "December 29, 2013", 
        "location": {
            "contact": {
                "email": "wliqing07@gmail.com", 
                "last_name": "Liqing Wang, Doctor", 
                "phone": "+86-02062783391"
            }, 
            "facility": {
                "address": {
                    "city": "Guangzhou", 
                    "country": "China", 
                    "state": "Guangdong", 
                    "zip": "510282"
                }, 
                "name": "Zhujiang Hospital,Southern Medical Universtiy"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Pharmacokinetic Drug Interaction Study to Evaluate the Effect of Azithromycin on the Steady-State Plasma Levels of Theophylline in a Chinese Population", 
        "overall_contact": {
            "email": "wliqing07@gmail.com", 
            "last_name": "Liqing Wang, Doctor", 
            "phone": "+86-02062783391"
        }, 
        "overall_official": {
            "affiliation": "Zhujiang Hospital,Southern Medical Unversity", 
            "last_name": "Liqing Wang, Doctor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Theophylline and it's metabolite(1,3-dimethyluric) blood concentration", 
            "measure": "steady-state plasma concentration of theophylline", 
            "safety_issue": "No", 
            "time_frame": "blood samples for theophylline will be collected on Days 8 and 15 before dosing"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02023554"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Zhujiang Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Zhujiang Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}